Kuros Biosciences AG

SIX:KURN.SW

19.64 (CHF) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income -13.727-15.991-9.554-12.094-11.823-13.813-16.593-20.2776.227-34.026-30.826-9.216-18.779-1.454-24.826-26.009-9.866-34.552-28.48-23.85
Depreciation & Amortization 2.7522.8342.882.6692.7141.9471.1470.820.0040.0090.0850.0751.7282.0512.4752.7382.8522.7942.5672.421
Deferred Income Tax -13.41500.13-0.11-0.863-2.0222.8563.0270-0.4790.788-0.2652.282-0.013-2.32801.6-0.90300
Stock Based Compensation 0.9171.030.3890.7520.4980.6752.0398.472.5333.7481.3090.8690.8651.0552.1422.7342.4242.48100
Change In Working Capital -3.649-1.266-0.187-0.73-1.3920.284-0.4760.039-0.156-7.9871.9090.3416.031-3.9216.436-9.298-1.8212.1690.2180.433
Accounts Receivables -4.572-1.641-0.737-0.375-0.476-0.2840.5070.394-0.09300000000000
Inventory -2.477-1.585-0.34-0.516-0.469-0.337-0.0790000000000000
Accounts Payables 0.0551.6410.7370.3750.4760000.16300000000000
Other Working Capital 3.3450.3190.153-0.214-0.9230.621-0.397-0.3551.21300000000000
Other Non Cash Items 18.2786.0450.8890.2740.0170.0910.349-0.972-11.11814.9777.565-3.341-0.934-2.4030.8531.940.413-0.663-1.383-1.686
Operating Cash Flow -8.844-7.348-5.453-9.239-10.849-12.838-10.678-8.893-2.514-23.758-19.17-11.537-8.807-4.685-15.248-27.895-4.398-28.674-27.078-22.682
Investing Activities:
Investments In Property Plant And Equipment -0.326-0.4-0.374-0.22-0.118-0.662-1.573-0.050-0.02-0.092-0.024-0.184-0.03-0.037-0.468-0.926-1.782-2.188-2.481
Acquisitions Net 000000.010.6531.8650000000-0.2030000
Purchases Of Investments 0000000000000000-48000
Sales Maturities Of Investments 0000000.0150000442940022.46100
Other Investing Activites -0.009-0.006-0.07-0.159-0.0330.010.015000.5910.2170.0410.130.1520.21127.21415.9040.708-1.57-24.147
Investing Cash Flow -0.326-0.4-0.374-0.22-0.118-0.652-0.9051.81500.5710.1254.0173.94629.1224.17426.543-33.02221.387-3.758-26.628
Financing Activities:
Debt Repayment -0.672-2.374-6.4-0.104-0.22000-14.23800-20.465-2.84-9.766-6.280-1.22-0.12500
Common Stock Issued 0.5016018.61514.30316.46916.3843.6572.2050.1924.60627.17100.0060.0240.444.7524.44221.78733.61
Common Stock Repurchased 0000000-0.193000-0.2240000-0.015000
Dividends Paid 00000000000000000000
Other Financing Activities -0.672-0.40212.478-1.434-0.957-1.451-0.405-0.193-0.28105.5255.088-1.182-1.496-2.024-2.07167.7790.61-0.515-1.164
Financing Cash Flow -0.1713.2246.07817.07713.12615.01815.9793.464-12.3140.1930.13111.57-4.022-11.256-8.28-1.63171.2964.92721.27232.446
Other Information:
Effect Of Forex Changes On Cash -0.516-0.034-0.01-0.0320.3090.133-0.0910.043-0.0140.0850.176-0.007-0.357-0.3680.0010.2620.0180.0400.058
Net Change In Cash -9.857-4.5580.2417.5862.4681.6614.304-3.571-14.842-22.91211.2624.043-9.2412.813-19.353-2.72133.894-2.32-9.564-16.806
Cash At End Of Period 14.20824.06528.62928.38820.80218.33416.67312.3692.09316.93539.84728.58524.54233.78220.96940.32243.0439.14911.46921.033